The invention provides canine CD20 nucleotide and protein sequences. These compositions are useful in the diagnosis and treatment of, e.g., CD20+ B-cell lymphoma, immune-mediated hemolytic anemia, immune-mediated thrombocytopenia, and systemic lupus erythematosus (SLE) in canines and felines.

 
Web www.patentalert.com

< Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi

> IL-31 monoclonal antibodies

> Monoclonal antibody inducing apoptosis

~ 00517